A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment
- PMID: 30922690
- DOI: 10.1016/j.eururo.2019.02.038
A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment
Abstract
Context: Current literature suggests that several pathophysiological factors and mechanisms might be responsible for the nonspecific symptom complex of overactive bladder (OAB).
Objective: To provide a comprehensive analysis of the potential pathophysiology underlying detrusor overactivity (DO) and OAB.
Evidence acquisition: A PubMed-based literature search was conducted in April 2018, to identify randomised controlled trials, prospective and retrospective series, animal model studies, and reviews.
Evidence synthesis: OAB is a nonspecific storage symptom complex with poorly defined pathophysiology. OAB was historically thought to be caused by DO, which was either "myogenic" (urgency initiated from autonomous contraction of the detrusor muscle) or "neurogenic" (urgency signalled from the central nervous system, which initiates a detrusor contraction). Patients with OAB are often found to not have objective evidence of DO on urodynamic studies; therefore, alternative mechanisms for the development of OAB have been postulated. Increasing evidence on the role of urothelium/suburothelium and bladder afferent signalling arose in the early 2000s, emphasising an afferent "urotheliogenic" hypothesis, namely, that urgency is initiated from the urothelium/suburothelium. The urethra has also recently been regarded as a possible afferent origin of OAB-the "urethrogenic" hypothesis. Several other pathophysiological factors have been implicated, including metabolic syndrome, affective disorders, sex hormone deficiency, urinary microbiota, gastrointestinal functional disorders, and subclinical autonomic nervous system dysfunctions. These various possible mechanisms should be considered as contributing to diagnostic and treatment algorithms.
Conclusions: There is a temptation to label OAB as "idiopathic" without obvious causation, given the poorly understood nature of its pathophysiology. OAB should be seen as a complex, multifactorial symptom syndrome, resulting from multiple potential pathophysiological mechanisms. Identification of the underlying causes on an individual basis may lead to the definition of OAB phenotypes, paving the way for personalised medical care.
Patient summary: Overactive bladder (OAB) is a storage symptom syndrome with multiple possible causes. Identification of the mechanisms causing a patient to experience OAB symptoms may help tailor treatment to individual patients and improve outcomes.
Keywords: Detrusor overactivity; Overactive bladder; Urinary incontinence; Urodynamics.
Copyright © 2019 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Comment in
-
Re: Benoit Peyronnet, Emma Mironska, Christopher Chapple, et al. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment. Eur Urol 2019;75:988-1000: Overactive Bladder Symptoms Can Be Caused by Pelvic Organ Prolapse.Eur Urol. 2019 Oct;76(4):e105-e106. doi: 10.1016/j.eururo.2019.07.003. Epub 2019 Jul 16. Eur Urol. 2019. PMID: 31320122 No abstract available.
-
Reply to Bernhard Liedl, Klaus Goeschen, and Florian Wagenlehner's Letter to the Editor re: Benoit Peyronnet, Emma Mironska, Christopher Chapple, et al. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment. Eur Urol 2019, 75:988-1000.Eur Urol. 2019 Oct;76(4):e107-e108. doi: 10.1016/j.eururo.2019.07.004. Epub 2019 Jul 18. Eur Urol. 2019. PMID: 31326217 No abstract available.
-
Re: A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment.Eur Urol. 2020 Jan;77(1):134-135. doi: 10.1016/j.eururo.2019.10.013. Epub 2019 Nov 6. Eur Urol. 2020. PMID: 31703970 No abstract available.
-
Re: A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment.J Urol. 2020 Aug;204(2):392. doi: 10.1097/JU.0000000000001118.02. Epub 2020 May 18. J Urol. 2020. PMID: 32421408 No abstract available.
Similar articles
-
Overactive bladder syndrome - focus onto detrusor overactivity.Scand J Urol. 2021 Feb;55(1):56-60. doi: 10.1080/21681805.2020.1839130. Epub 2020 Oct 29. Scand J Urol. 2021. PMID: 33118417
-
[Terminology and Pathophysiology of Overactive Bladder (OAB)].Aktuelle Urol. 2016 Dec;47(6):468-474. doi: 10.1055/s-0042-108871. Epub 2016 Sep 6. Aktuelle Urol. 2016. PMID: 27598780 Review. German.
-
The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: pathophysiology and pharmacotherapy of overactive bladder.J Pharmacol Sci. 2010;112(2):128-34. doi: 10.1254/jphs.09r12fm. Epub 2010 Feb 4. J Pharmacol Sci. 2010. PMID: 20134115 Review.
-
Is there any association between urodynamic variables and severity of overactive bladder in women with idiopathic detrusor overactivity?Neurourol Urodyn. 2017 Mar;36(3):780-783. doi: 10.1002/nau.23023. Epub 2016 Apr 19. Neurourol Urodyn. 2017. PMID: 27092808
-
Urothelial mucosal signaling and the overactive bladder-ICI-RS 2013.Neurourol Urodyn. 2014 Jun;33(5):597-601. doi: 10.1002/nau.22604. Epub 2014 May 16. Neurourol Urodyn. 2014. PMID: 24838393 Free PMC article.
Cited by
-
Urinary Levels of miR-491-5p and miR-592 as Potential Diagnostic Biomarkers in Female Aging Patients with OAB: A Pilot Study.Metabolites. 2022 Aug 31;12(9):820. doi: 10.3390/metabo12090820. Metabolites. 2022. PMID: 36144224 Free PMC article.
-
Lax Uterosacral Ligament and Urge Urinary Incontinence: MRI Findings in Symptomatic Patients Versus Healthy Volunteers.Int Urogynecol J. 2024 Apr;35(4):793-801. doi: 10.1007/s00192-023-05722-y. Epub 2024 Jan 19. Int Urogynecol J. 2024. PMID: 38240800 Free PMC article.
-
The Urobiome and Its Role in Overactive Bladder.Int Neurourol J. 2022 Sep;26(3):190-200. doi: 10.5213/inj.2244016.008. Epub 2022 Apr 22. Int Neurourol J. 2022. PMID: 35468617 Free PMC article.
-
Piezo channels in the urinary system.Exp Mol Med. 2022 Jun;54(6):697-710. doi: 10.1038/s12276-022-00777-1. Epub 2022 Jun 14. Exp Mol Med. 2022. PMID: 35701561 Free PMC article. Review.
-
Pharmacological Management of Urinary Incontinence: Current and Emerging Treatment.Clin Pharmacol. 2021 Nov 25;13:209-223. doi: 10.2147/CPAA.S289323. eCollection 2021. Clin Pharmacol. 2021. PMID: 34858068 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous